CN104027672A - Traditional Chinese medicine composition for treating psoriasis - Google Patents

Traditional Chinese medicine composition for treating psoriasis Download PDF

Info

Publication number
CN104027672A
CN104027672A CN201410316680.8A CN201410316680A CN104027672A CN 104027672 A CN104027672 A CN 104027672A CN 201410316680 A CN201410316680 A CN 201410316680A CN 104027672 A CN104027672 A CN 104027672A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
medicine composition
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410316680.8A
Other languages
Chinese (zh)
Inventor
华菊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410316680.8A priority Critical patent/CN104027672A/en
Publication of CN104027672A publication Critical patent/CN104027672A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating psoriasis. The traditional Chinese medicine composition for treating psoriasis is composed of, by weight, 25-31 parts of semen coicis, 17-23 parts of dried rehmanniae roots, 17-23 parts of radix bupleuri, 17-23 parts of pueraria lobata, 17-23 parts of radix scrophulariae, 17-23 parts of isatis roots, 17-23 parts of radix sophorae flavescentis, 17-23 parts of herba artemisiae capillariae, 17-23 parts of cortex dictamni, 9-15 parts of radix clematidis, 9-15 parts of common peony roots, 9-15 parts of blackberry lily, 9-15 parts of platycodon grandiflorus and 9-15 parts of lingusticum wallichii. The traditional Chinese medicine composition for treating psoriasis has the advantages of being stable in curative effect and free of side effect.

Description

One is treated psoriatic Chinese medicine composition
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to one and treat psoriatic Chinese medicine composition.
Background technology
Psoriasis is commonly called as psoriasis, is a kind of chronic inflammatory disease dermatoses, and the course of disease is longer, has easy tendency of recurrence, and some cases almost cannot be cured all one's life.This disease is fallen ill taking person between twenty and fifty as main, larger on patient's healthy and mental status impact.Clinical manifestation is with erythema, and squama is main, and whole body all can be fallen ill, and with scalp, it is comparatively common that extremity are stretched side, how to increase the weight of in the winter time.
At present, treat psoriatic medicine more, but have the deficiencies such as curative effect is unstable, side effect is large.
Summary of the invention
1) technical problem that will solve
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides one and treat psoriatic Chinese medicine composition, the present invention has advantages of stable curative effect, has no side effect.
2) technical scheme
One is treated psoriatic Chinese medicine composition, is made up of the crude drug of following weight portion: Semen Coicis 25-31 part, Radix Rehmanniae 17-23 part, Radix Bupleuri 17-23 part, Radix Puerariae 17-23 part, Radix Scrophulariae 17-23 part, Radix Isatidis 17-23 part, Radix Sophorae Flavescentis 17-23 part, Herba Artemisiae Scopariae 17-23 part, Cortex Dictamni 17-23 part, Radix Clematidis 9-15 part, Radix Paeoniae Rubra 9-15 part, Rhizoma Belamcandae 9-15 part, Radix Platycodonis 9-15 part, Rhizoma Chuanxiong 9-15 part.
The psoriatic Chinese medicine composition of described treatment, it is preferably made up of the crude drug of following weight portion: 28 parts of Semen Coiciss, 20 parts of Radix Rehmanniae, 20 parts of Radix Bupleuri, 20 parts of Radix Puerariaes, 20 parts of Radix Scrophulariaes, 20 parts of Radix Isatidis, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Herba Artemisiae Scopariaes, 20 parts of Cortex Dictamni, 12 parts of Radix Clematidis, 12 parts of Radix Paeoniae Rubra, 12 parts of Rhizoma Belamcandae, 12 parts of Radix Platycodoniss, 12 parts of Rhizoma Chuanxiongs.
The preparation method of the described psoriatic Chinese medicine composition for the treatment of is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
The application of the psoriatic Chinese medicine composition of described treatment in preparation treatment psoriasis.
3) beneficial effect
The beneficial effect that the present invention compared with prior art had is: the present invention is under Traditional Chinese medical theory and clinical experience guidance, chooses each crude drug and proportioning thereof, has the function of heat-clearing and toxic substances removing, removing heat from blood dampness removing, realizes the psoriatic object for the treatment of.The present invention treats psoriasis to be had advantages of stable curative effect, has no side effect.
Below in conjunction with clinical experiment, beneficial effect of the present invention is described:
(1) clinical data: the present invention treats psoriatic's 48 examples altogether, wherein, male 27 examples, female's 21 examples, the age is 12-65 year.
(2) Therapeutic Method: the oral drugs that Chinese medicine composition of the present invention is made can be decoction, tablet, pill and capsule etc., taking decoction as example, 1 pair of every day, point takes for 2 times, early, respectively take 1 evening, within 20 days, is 1 course for the treatment of.
(3) the standard of curative effect evaluation:
Cure: skin lesion disappears completely, or disappears more than 95%.
Take a turn for the better: skin lesion disappears more than 50%.
Do not heal: the skin lesion less than 50% that disappears.
(4) therapeutic outcome: the present invention treats psoriatic's 48 examples altogether, through 1-4 course of therapy, cures 40 examples, accounts for 83.3%, and 6 examples that take a turn for the better, account for 12.5%, and 2 examples that do not heal, account for 4.2%, and effective percentage is 95.8%, has no any side effect; Cure in 40 examples, cure 7 examples 1 course for the treatment of, cure 10 examples 2 courses for the treatment of, cure 14 examples 3 courses for the treatment of, cure 9 examples 4 courses for the treatment of, follows up a case by regular visits to half by 1 year after healing, is showed no recurrence; Result shows, the present invention has advantages of stable curative effect, has no side effect.
(5) model case:
1, Yang, man, 12 years old, patient's flushed face, lip is dry, whole body desquamation, and dizzy nauseating.Examine as psoriasis.Take Chinese medicine composition of the present invention and cure 1 course for the treatment of, after half a year, follow up a case by regular visits to, not recurrence.
2, side certain, female, 47 years old, extremity stretch side and red rash first quarter moon appears in back, occurred the large pimple of Semen Glycines and patch on skin lesion, above covered silver bits.Take Chinese medicine composition of the present invention and cure 2 courses for the treatment of, after 1 year, follow up a case by regular visits to, not recurrence.
Detailed description of the invention
Embodiment 1:
One is treated psoriatic Chinese medicine composition, is made up of the crude drug of following weight portion: 25 parts of Semen Coiciss, 17 parts of Radix Rehmanniae, 17 parts of Radix Bupleuri, 17 parts of Radix Puerariaes, 17 parts of Radix Scrophulariaes, 17 parts of Radix Isatidis, 17 parts of Radix Sophorae Flavescentiss, 17 parts of Herba Artemisiae Scopariaes, 17 parts of Cortex Dictamni, 9 parts of Radix Clematidis, 9 parts of Radix Paeoniae Rubra, 9 parts of Rhizoma Belamcandae, 9 parts of Radix Platycodoniss, 9 parts of Rhizoma Chuanxiongs.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 2:
One is treated psoriatic Chinese medicine composition, is made up of the crude drug of following weight portion: 28 parts of Semen Coiciss, 20 parts of Radix Rehmanniae, 20 parts of Radix Bupleuri, 20 parts of Radix Puerariaes, 20 parts of Radix Scrophulariaes, 20 parts of Radix Isatidis, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Herba Artemisiae Scopariaes, 20 parts of Cortex Dictamni, 12 parts of Radix Clematidis, 12 parts of Radix Paeoniae Rubra, 12 parts of Rhizoma Belamcandae, 12 parts of Radix Platycodoniss, 12 parts of Rhizoma Chuanxiongs.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 3:
One is treated psoriatic Chinese medicine composition, is made up of the crude drug of following weight portion: Semen Coicis 25-31 part, 23 parts of Radix Rehmanniae, 23 parts of Radix Bupleuri, 23 parts of Radix Puerariaes, 23 parts of Radix Scrophulariaes, 23 parts of Radix Isatidis, 23 parts of Radix Sophorae Flavescentiss, 23 parts of Herba Artemisiae Scopariaes, 23 parts of Cortex Dictamni, 15 parts of Radix Clematidis, 15 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Belamcandae, 15 parts of Radix Platycodoniss, 15 parts of Rhizoma Chuanxiongs.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.

Claims (4)

1. the psoriatic Chinese medicine composition for the treatment of, is characterized in that: the crude drug by following weight portion is made: Semen Coicis 25-31 part, Radix Rehmanniae 17-23 part, Radix Bupleuri 17-23 part, Radix Puerariae 17-23 part, Radix Scrophulariae 17-23 part, Radix Isatidis 17-23 part, Radix Sophorae Flavescentis 17-23 part, Herba Artemisiae Scopariae 17-23 part, Cortex Dictamni 17-23 part, Radix Clematidis 9-15 part, Radix Paeoniae Rubra 9-15 part, Rhizoma Belamcandae 9-15 part, Radix Platycodonis 9-15 part, Rhizoma Chuanxiong 9-15 part.
2. the psoriatic Chinese medicine composition for the treatment of according to claim 1, is characterized in that: the crude drug by following weight portion is made: 28 parts of Semen Coiciss, 20 parts of Radix Rehmanniae, 20 parts of Radix Bupleuri, 20 parts of Radix Puerariaes, 20 parts of Radix Scrophulariaes, 20 parts of Radix Isatidis, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Herba Artemisiae Scopariaes, 20 parts of Cortex Dictamni, 12 parts of Radix Clematidis, 12 parts of Radix Paeoniae Rubra, 12 parts of Rhizoma Belamcandae, 12 parts of Radix Platycodoniss, 12 parts of Rhizoma Chuanxiongs.
3. the preparation method of the psoriatic Chinese medicine composition for the treatment of according to claim 1 and 2, is characterized in that: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
4. the application of the psoriatic Chinese medicine composition for the treatment of according to claim 1 and 2 in preparation treatment psoriasis.
CN201410316680.8A 2014-07-06 2014-07-06 Traditional Chinese medicine composition for treating psoriasis Pending CN104027672A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410316680.8A CN104027672A (en) 2014-07-06 2014-07-06 Traditional Chinese medicine composition for treating psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410316680.8A CN104027672A (en) 2014-07-06 2014-07-06 Traditional Chinese medicine composition for treating psoriasis

Publications (1)

Publication Number Publication Date
CN104027672A true CN104027672A (en) 2014-09-10

Family

ID=51458816

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410316680.8A Pending CN104027672A (en) 2014-07-06 2014-07-06 Traditional Chinese medicine composition for treating psoriasis

Country Status (1)

Country Link
CN (1) CN104027672A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1704105A (en) * 2004-05-28 2005-12-07 陈金海山 Chinese traditional medicine composition for treating psoriasis
CN1739753A (en) * 2004-08-27 2006-03-01 闫晓东 Psoriasis treating Chinese medicine prepn and its pren process
CN102106937A (en) * 2011-02-23 2011-06-29 徐海彬 Medicament for treating psoriasis
CN103142903A (en) * 2013-03-14 2013-06-12 青岛市市立医院 Traditional Chinese medicine preparation for treating psoriasis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1704105A (en) * 2004-05-28 2005-12-07 陈金海山 Chinese traditional medicine composition for treating psoriasis
CN1739753A (en) * 2004-08-27 2006-03-01 闫晓东 Psoriasis treating Chinese medicine prepn and its pren process
CN102106937A (en) * 2011-02-23 2011-06-29 徐海彬 Medicament for treating psoriasis
CN103142903A (en) * 2013-03-14 2013-06-12 青岛市市立医院 Traditional Chinese medicine preparation for treating psoriasis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
易磊等: "《中医验方大全》", 31 May 2013, article "银屑病", pages: 429-434 *
罗清等: "中医药治疗银屑病近况", 《时珍国医国药》, vol. 15, no. 12, 31 December 2004 (2004-12-31), pages 871 - 872 *
赵振波: "银屑病中医治疗体会", 《陕西中医》, vol. 30, no. 1, 31 December 2009 (2009-12-31), pages 124 - 125 *

Similar Documents

Publication Publication Date Title
CN102920984A (en) Medicine for curing rheumatoid arthritis
CN103860992A (en) Traditional Chinese medicinal lotion for treating infantile eczema
CN103356968B (en) Traditional Chinese medicine composition for treating endometriosis
CN104042737A (en) External medicinal composition for treating acute eczema and preparation method thereof
CN104027557A (en) Traditional Chinese medicine composition for treating folliculitis
CN103845429A (en) Traditional Chinese medicine for treating chronic hepatitis
CN103417774B (en) Traditional Chinese medicine and preparing method and application thereof
CN103301411A (en) Traditional Chinese medicine wine for treating soft tissue injury and preparation method thereof
CN104027672A (en) Traditional Chinese medicine composition for treating psoriasis
CN104042970A (en) Traditional Chinese medicine (TCM) composition for allergic purpura
CN103860952A (en) Traditional Chinese medicine lotion for treating vulva pruritus
CN104248691A (en) Medicament for the treatment of prurigo nodularis
CN103463611B (en) Traditional Chinese medicine composite for treating seborrhoeic alopecia and preparing method thereof
CN106166287A (en) A kind of Chinese medicine for treating skin pruritus
CN104510861A (en) Traditional Chinese medicine for treating rheumatoid disease
CN105535922A (en) Externally-used medicine for treating soft tissue injuries and preparation method of externally-used medicine
CN105362800A (en) Medicament of treating varicosity
CN105343803A (en) Traditional Chinese medicine ointment for treating gynecological inflammation
CN104740565A (en) Traditional Chinese medicine composition for treating cold injury
CN104042728A (en) Traditional Chinese medicine for treating rectocele
CN104027404A (en) Traditional Chinese medicine washing liquor used for treating leukoplakia vulvae
CN104383274A (en) Traditional Chinese medicine composition controlling hemorrhoid postoperation infection
CN103860975A (en) Traditional Chinese medicine for treating psoriasis
CN103272035B (en) Sphacelus treatment medicine
CN104056205A (en) Traditional Chinese medicine composition for treating erythema nodosum

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Hua Ju

Document name: reexamine notice

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140910